Invention Grant
- Patent Title: Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof
-
Application No.: US15215690Application Date: 2016-07-21
-
Publication No.: US10280231B2Publication Date: 2019-05-07
- Inventor: Sanjaya Singh , Qi Pan , Rachel Rebecca Barrett , Leslie S. Johnson , Pankaj Gupta , Sarah Low , Haixia Wu
- Applicant: Boehringer Ingelheim International GmbH , MacroGenics, Inc.
- Applicant Address: DE Ingelheim am Rhein US MD Rockville
- Assignee: Boehringer Ingelheim International GmbH,MacroGenics, Inc.
- Current Assignee: Boehringer Ingelheim International GmbH,MacroGenics, Inc.
- Current Assignee Address: DE Ingelheim am Rhein US MD Rockville
- Agency: LeClairRyan PLLC
- Agent Robin L. Teskin
- Main IPC: C07K16/46
- IPC: C07K16/46 ; A61K39/395 ; C07K16/24 ; C07K16/28 ; A61K39/00
Abstract:
The disclosure relates to compounds specific for IL23A and BAFF, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
Public/Granted literature
- US20170022294A1 COMPOUND TARGETING IL-23A AND B-CELL ACTIVATING FACTOR (BAFF) AND USES THEREOF Public/Granted day:2017-01-26
Information query
